Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
October 14, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
James Altucher Offers Investment Research Strategies to “AI 2.0”
October 11, 2024 18:25 ET
|
James Altucher, Tech Investor
New York, New York, Oct. 11, 2024 (GLOBE NEWSWIRE) -- New York, NY — “AI 2.0 isn’t just a step forward, it’s a giant leap,” says James Altucher. “It’s the kind of advancement that opens doors to the...
NEXGEL to Participate in Upcoming October Investor Conferences
October 11, 2024 09:00 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
October 11, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
October 11, 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
October 10, 2024 10:00 ET
|
Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
October 09, 2024 16:15 ET
|
Genelux Corporation
WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO...
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
October 09, 2024 10:47 ET
|
Lipella Pharmaceuticals Inc.
PITTSBURGH, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases...
Pillar Security’s State of Attacks on GenAI: 90% of Successful Attacks Seen in the Wild Resulted in Leaked Sensitive Data
October 09, 2024 07:00 ET
|
Pillar Security
TEL AVIV, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Pillar Security, a pioneering company in GenAI security solutions, today released the industry’s first "State of Attacks on GenAI" research based on...
Tenable Cloud Risk Report Sounds the Alarm on Toxic Cloud Exposures Threatening Global Organizations
October 08, 2024 09:00 ET
|
Tenable Holdings, Inc.
COLUMBIA, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Tenable®, the exposure management company, today released its 2024 Tenable Cloud Risk Report, which examines the critical risks at play in modern...